Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
Indian J Lepr
; 59(1): 36-43, 1987.
Article
em En
| MEDLINE
| ID: mdl-3611859
ABSTRACT
56 lepromatous leprosy patients with an initial average BI of 4.45 were administered once a month 600 mg of Rifampicin, 100 mg of Clofazimine on alternate days and 100 mg of Dapsone daily. None of these patients became smear negative in 2 years, and the same regimen was continued further. Two patients have become negative in 3 years and treatment has been stopped in them. The study indicates that highly bacilliferous LL/BL patients are likely to need 3 years or more of MDT for achieving bacterial negativity.
Buscar no Google
Tema:
Complicacoes
/
Geral
/
Tratamento_medicamentoso
Bases de dados:
MEDLINE
Assunto principal:
Rifampina
/
Clofazimina
/
Dapsona
/
Hanseníase
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Indian J Lepr
Ano de publicação:
1987
Tipo de documento:
Article